Rankings
▼
Calendar
DSGN
Design Therapeutics, Inc.
$569M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$5,000
Operating Income
-$9M
Net Income
-$8M
EPS (Diluted)
$-0.30
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$450,000
Balance Sheet
Total Assets
$37M
Total Liabilities
$48M
Stockholders' Equity
-$11M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$834
-100.0%
Gross Profit
-$5,000
-$820
-509.8%
Operating Income
-$9M
-$2M
-348.4%
Net Income
-$8M
-$2M
-304.5%
← FY 2019
All Quarters
Q1 2020 →
DSGN FY 2020 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena